Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development
Authors:
Open Access
- 31 May 2018
- journal article
- research article
- Published by Biomedical Informatics in Bioinformation
- Vol. 14 (05) , 183-189
Abstract
Influenza viruses A and B are important human respiratory pathogens causing seasonal, endemic and pandemic infections in several parts of the globe with high morbidity and considerable mortality. The current inactivated and live attenuated vaccines are not effective. Therefore, it is of interest to design universal influenza virus vaccines with high efficacy. The peptide GQSVVSVKLAGNSSL of pandemic influenza, the peptide DKTSVTLAGNSSLCS of seasonal influenza and the peptide DILLKFSPTEITAPT of influenza B were identified as potential linear cell mediated epitopes. The epitopes predicted by BepiPred (B-cell epitope designer) program was subjected to docking experiment-using HexDock and CABS dock programs. The epitopes of pandemic H1N1 influenza A gave similar score of high affinity in docking. The epitope DKTSVTLAGNSSLCS of seasonal influenza A and epitope DILLKFSPTEITAPT of influenza B had high binding energy. It is further observed that the peptides GQSVVSVKLAGNSSL (pandemic influenza), DKTSVTLAGNSSLCS (seasonal influenza) DILLKFSPTEITAPT (influenza B) are found to interact with some known MHC class II alleles. These peptides have high-affinity binding with known MHC class II alleles. Thus, they have the potential to elicit cell immune response. These vaccines have to be further evaluated in animal models and human volunteers. These findings have application in the development of peptide B-cell epitope vaccines against influenza viruses.Keywords
This publication has 41 references indexed in Scilit:
- Novel Platforms for the Development of a Universal Influenza VaccineFrontiers in Immunology, 2018
- Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza seasonVaccine, 2017
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsProceedings of the National Academy of Sciences, 2017
- Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studiesJournal of Infection, 2017
- A clinical approach to the threat of emerging influenza viruses in the Asia‐Pacific regionRespirology, 2017
- BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopesNucleic Acids Research, 2017
- Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selectionNature Communications, 2015
- The I-TASSER Suite: protein structure and function predictionNature Methods, 2014
- Extensive Geographical Mixing of 2009 Human H1N1 Influenza A Virus in a Single University CommunityJournal of Virology, 2011
- The novel influenza A (H1N1) virus pandemic: An updateAnnals of Thoracic Medicine, 2009